Project Grant K23HL169833
Award Date
6/1/24
Completion Date
5/31/29
Dollars Obligated
$161K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This federal Project Grant award, with ID R21HL175536, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The $117,750 award is supporting a study to investigate the prospective associations between neighborhood environment features and physical activity levels as well as weight status across different age groups, including children, adolescents, adults, and older adults.
The key activities include leveraging...
This $364,879 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research by Dr. Jasleen Minhas at the University of Pennsylvania to investigate patterns of heart rate and daily physical activity in patients with pulmonary arterial hypertension (PAH).
The key objectives are to: 1) identify determinants of heart rate and physical activity patterns in PAH, 2) develop novel phenotypes by...
The Children's Hospital of Philadelphia (CHOP) was awarded a $985,424 federal Project Grant by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant project aims to evaluate the efficacy of a home-based, digital intervention to increase physical activity and improve physical fitness outcomes in youth with the Fontan circulation, a complex congenital heart condition.
The study will involve a randomized controlled trial...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $154,004 to Texas A&M University System Health Science Center to evaluate the feasibility of using Ecological Momentary Assessment (EMA) and Social Network Analysis (SNA) techniques to study the relationships between social and built environments and physical activity among 100 youth during the summer months. The project aims...
This federal Project Grant award, R01HL174691, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The $809,029 award will fund a 5-year randomized controlled trial to evaluate the effectiveness of gamification and social incentives in increasing physical activity adherence among patients with heart failure with preserved ejection fraction (HFPEF). The study aims to determine if this low-cost, scalable...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support the advancement of Dr. Lachant as an independent physician-scientist focused on conducting research to improve rehabilitation and outcomes for patients with pulmonary embolism.
The $374,592 award will fund a mentored research project to study the impact of an electronically-delivered home rehabilitation program initiated within 7...
This $166,746 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support an investigation into the long-term cardiovascular health impacts of in-utero exposure to mild chronic hypertension and antihypertensive therapy. The primary objectives are to 1) assess whether in-utero exposure to antihypertensive treatment is associated with improved subclinical cardiovascular disease (CVD) risk factors in...
The University of Colorado-Denver received a $126,059 Project Grant from the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports a 5-year research project to investigate the systems biology of acute and chronic multi-organ failure in children with congenital heart disease (CHD).
Specifically, the research will utilize proximity extension assay technology to perform longitudinal measurement of the circulating proteome...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $760,403 project grant under the Cardiovascular Diseases Research program (CFDA 93.837) to New York University (NYU) School of Medicine. The purpose of this 5-year grant, awarded on July 1, 2024, is to study the long-term, population-level impact of a school-based, parenting-focused intervention to prevent obesity among Black and Latinx children living in historically disinvested neighborhoods. The research aims to evaluate the...
This federal Project Grant award of $145,910.00 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support a five-year observational study at the Children's Hospital of Philadelphia (CHOP). The study aims to assess myocardial dysfunction and inflammation in 200 critically ill children after cardiac arrest. The research will leverage advanced echocardiographic imaging techniques and biomarker analysis to examine...